WHO spokesperson addresses health, medical needs for Libya on PBS NewsHour

NewsGuard 100/100 Score

The WHO "is rushing to secure medical supplies for Libya" after the Dutch government on Monday released nearly $145 million in frozen assets from Libyan leader Moammar Qaddafi's regime in response to a direct WHO appeal, PBS NewsHour reports.  The news service features an interview with Tarik Jasarevic, WHO spokesperson for medical emergencies, who spoke "about the health needs in Libya and how the funds will be used."

Since violent conflict began in February, "the health system has managed to prevent disease outbreaks and maintain a high level of immunization" but now "stocks of vaccines, insulin, chemotherapy, laboratory consumables and HIV drugs are really running short and some of them by the end of September will no longer be available," Jasarevic said. He added that some supplies may take up to three months to reach the country, and though WHO will respond immediately by "sending pre-positioned medical kits, … these kits do not contain some very important medicines, so we are really now racing against time" (Miller, 8/18).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.